Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The frequency and prognostic role of P53 and P16 immunoexpression in primary ovarian mucinous tumors.

Annals of diagnostic pathology - 1 Oct 2024

Nergiz Döndü, Yıldırım Hülya Tosun, Süren Dinç, Sadullahoğlu Canan, Yıldırım Şenay, Üreyen Işın

Abstract excerpt

BACKGROUND: Primary ovarian mucinous tumors are uncommon. Factors leading to invasive progression and metastatic disease have not been fully delineated yet. The aim of this study is to determine the rates of p53 and p16 immunoexpressions in primary ovarian mucinous tumors, to investigate their relationship with clinicopathologic factors and their impact on prognosis and survival. METHODS: Seventy-eight primary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Mucinous
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Immunohistochemistry

Share to Ovarian Neoplasms

Share to Prognosis

Share to Tumor Suppressor Protein p53

Share to Young Adult

Source

Identifiers

PMID: 38772285
DOI: 10.1016/j.anndiagpath.2024.152330

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The frequency and prognostic role of P53 and P16 immunoexpression in primary ovarian mucinous tumors.PMID 38772285Read ↗

Mucinous epithelial ovarian carcinoma.Semantic proximity Read ↗

Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers.Semantic proximity Read ↗

Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations.Semantic proximity Read ↗

Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance.Semantic proximity Read ↗

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.Semantic proximity Read ↗

Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.Semantic proximity Read ↗

A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors.Semantic proximity Read ↗

Ovarian Mucinous Tumor with Mural Nodules of Anaplastic Carcinoma: A Clinicopathological Analysis of Three Cases Report and Review of Related LiteratureSemantic proximity Read ↗

Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high-grade serous carcinoma from ascites.Semantic proximity Read ↗

Two types of primary mucinous ovarian tumors can be distinguished based on their origin.Semantic proximity Read ↗

[Molecular genetics of epithelial ovarian neoplasms: correlations with phenotype and biological behavior].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.